Ionis Pharmaceuticals IONS PP&E Sale Proceeds
PP&E Sale Proceeds at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's pp&e sale proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ionis Pharmaceuticals's PP&E sale proceeds?
- Ionis Pharmaceuticals (IONS) reported PP&E sale proceeds of $19.6M in Q3 2025.
- What does PP&E sale proceeds mean?
- Cash received from selling company-owned equipment, buildings, or land.
- How do you interpret PP&E sale proceeds?
- Higher proceeds indicate successful asset liquidation or efficient capital recycling.
- How does PP&E sale proceeds compare across companies?
- Standard line item in the Investing section of the Cash Flow statement for all asset-heavy industries.